197 related articles for article (PubMed ID: 11113703)
21. In vitro and in vivo mutagenicity of the butadiene metabolites butadiene diolepoxide, butadiene monoepoxide and diepoxybutane.
Adler ID; Kliesch U; Nylund L; Peltonen K
Mutagenesis; 1997 Sep; 12(5):339-45. PubMed ID: 9379912
[TBL] [Abstract][Full Text] [Related]
22. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
23. A novel DNA adduct, originating from 1,2-epoxy-3,4-butanediol, is the major DNA adduct after exposure to [2,3-(14)C]-1,3-butadiene,[4-(14)C]-1,2-epoxy-3-butane.
Boogaard PJ; van Sittert NJ; Watson WP; de Kloe KP
Chem Biol Interact; 2001 Jun; 135-136():687-93. PubMed ID: 11397423
[TBL] [Abstract][Full Text] [Related]
24. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
25. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
[TBL] [Abstract][Full Text] [Related]
27. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
Seaton MJ; Follansbee MH; Bond JA
Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
[TBL] [Abstract][Full Text] [Related]
28. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
Himmelstein MW; Asgharian B; Bond JA
Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
[TBL] [Abstract][Full Text] [Related]
29. Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane.
Anderson D; Dobrzyńka MM; Jackson LI; Yu TW; Brinkworth MH
Mutat Res; 1997 Jul; 391(3):233-42. PubMed ID: 9268048
[TBL] [Abstract][Full Text] [Related]
30. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.
Johanson G; Filser JG
Arch Toxicol; 1993; 67(3):151-63. PubMed ID: 8494494
[TBL] [Abstract][Full Text] [Related]
31. 1,3-Butadiene: II. Genotoxicity profile.
Albertini RJ; Carson ML; Kirman CR; Gargas ML
Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():12-73. PubMed ID: 20868267
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel metabolites of butadiene monoepoxide in rats and mice.
Richardson KA; Peters MM; Megens RH; van Elburg PA; Golding BT; Boogaard PJ; Watson WP; van Sittert NJ
Chem Res Toxicol; 1998 Dec; 11(12):1543-55. PubMed ID: 9860500
[TBL] [Abstract][Full Text] [Related]
33. Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes.
Nieusma JL; Claffey DJ; Maniglier-Poulet C; Imiolczyk T; Ross D; Ruth JA
Chem Res Toxicol; 1997 Apr; 10(4):450-6. PubMed ID: 9114983
[TBL] [Abstract][Full Text] [Related]
34. Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro.
Boogaard PJ; Sumner SC; Bond JA
Toxicol Appl Pharmacol; 1996 Feb; 136(2):307-16. PubMed ID: 8619238
[TBL] [Abstract][Full Text] [Related]
35. Detoxification of olefinic epoxides and nucleotide excision repair of epoxide-mediated DNA damage: Insights from animal models examining human sensitivity to 1,3-butadiene.
Wickliffe JK; Herring SM; Hallberg LM; Galbert LA; Masters OE; Ammenheuser MM; Xie J; Friedberg EC; Lloyd RS; Abdel-Rahman SZ; Ward JB
Chem Biol Interact; 2007 Mar; 166(1-3):226-31. PubMed ID: 16730686
[TBL] [Abstract][Full Text] [Related]
36. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
Fred C; Grawé J; Törnqvist M
Mutat Res; 2005 Aug; 585(1-2):21-32. PubMed ID: 15925539
[TBL] [Abstract][Full Text] [Related]
37. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
38. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice.
Cochrane JE; Skopek TR
Carcinogenesis; 1994 Apr; 15(4):719-23. PubMed ID: 8149486
[TBL] [Abstract][Full Text] [Related]
39. Stereochemical aspects of the conjugation of epoxide metabolites of butadiene with glutathione in rat liver cytosol and freshly isolated rat hepatocytes.
Nieusma JL; Claffey DJ; Ruth JA; Ross D
Toxicol Sci; 1998 Jun; 43(2):102-9. PubMed ID: 9710951
[TBL] [Abstract][Full Text] [Related]
40. Analysis of micronuclei induced by 1,3-butadiene and its metabolites using fluorescence in situ hybridization.
Xiao Y; de Stoppelaar JM; Hoebee B; Schriever-Schwemmer G; Adler ID; Tates AD
Mutat Res; 1996 Jul; 354(1):49-57. PubMed ID: 8692206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
